Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: Results from a phase 1/2 clinical trial

Dali, Christine, I; Sevin, Caroline; Kraegeloh-Mann, Ingeborg; Giugliani, Roberto; Sakai, Norio; Wu, James; Wasilewski, Margaret

dc.contributor.author	Krägeloh-Mann, Ingeborg
dc.date.accessioned	2022-03-14T07:23:32Z
dc.date.available	2022-03-14T07:23:32Z
dc.date.issued	2020
dc.identifier.issn	1096-7206
dc.identifier.uri	http://hdl.handle.net/10900/125330
dc.language.iso	en	de_DE
dc.publisher	Academic Press Inc Elsevier Science	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.ymgme.2020.07.002	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: Results from a phase 1/2 clinical trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20210304112512_01562
utue.publikation.seiten	235-244	de_DE
utue.personen.roh	Dali, Christine, I
utue.personen.roh	Sevin, Caroline
utue.personen.roh	Kraegeloh-Mann, Ingeborg
utue.personen.roh	Giugliani, Roberto
utue.personen.roh	Sakai, Norio
utue.personen.roh	Wu, James
utue.personen.roh	Wasilewski, Margaret
dcterms.isPartOf.ZSTitelID	Molecular Genetics and Metabolism	de_DE
dcterms.isPartOf.ZS-Issue	1-2	de_DE
dcterms.isPartOf.ZS-Volume	131	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE